Venus Medtech (启明医疗) IPO: Technical Comparison of VenusA-Valve and Peers
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
989 Views
Venus Medtech (启明医疗) IPO: Has the Elements for a Hot Healthcare Deal
Venus Medtech, a China Hangzhou-based transcatheter heart valve medical device player, is looking to raise up to USD 300 million via a listing in...
1.2k Views
Last Week in GER Research: WeWork, Venus Medtech, Fineos, Takara Leben, TPV Tech, and Douya/Huya
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week, we dig into the stretched balance...
610 Views
Venus Medtech IPO Initiation: The Heart of the Business
Venus MedTech Hangzhou Inc (1392140D CH) is a leading transcatheter heart valve medical device company in China. VenusA-Valve, a self-developed...
915 Views
Venus Medtech IPO: First Mover Advantage in Chinese TAVR Market to Support Growth
Venus Medtech is a leading transcatheter heart valve medical device maker based in China. It is the first company to obtain CFDA approval for...
810 Views